Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86060062 | 8606006 | 2 | F | 20160728 | 20120608 | 20160804 | EXP | US-ASTRAZENECA-2011SE65296 | ASTRAZENECA | 62.00 | YR | F | Y | 53.50000 | KG | 20160804 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86060062 | 8606006 | 1 | PS | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 20838 | 16 | MG | TABLET | QD | |||||||
| 86060062 | 8606006 | 2 | SS | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 20838 | 8 | MG | TABLET | QD | |||||||
| 86060062 | 8606006 | 3 | SS | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 16 MG; CUTTING THE ATACAND 16MG AND TAKING HALF A TABLET. | 20838 | TABLET | |||||||||
| 86060062 | 8606006 | 4 | SS | ALPHA BLOCKER | UNSPECIFIED INGREDIENT | 1 | Unknown | U | 0 | ||||||||||
| 86060062 | 8606006 | 5 | C | CLONIPINE | CLONAZEPAM | 1 | 0 | ||||||||||||
| 86060062 | 8606006 | 6 | C | LEXAPRIL | ESCITALOPRAM OXALATE | 1 | 0 | ||||||||||||
| 86060062 | 8606006 | 7 | C | BLOOD PRESSURE MEDICATION/DIURETICS/CHANNEL BLOCKER | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 86060062 | 8606006 | 1 | Hypertension |
| 86060062 | 8606006 | 2 | Hypertension |
| 86060062 | 8606006 | 3 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 86060062 | 8606006 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 86060062 | 8606006 | Adverse drug reaction | |
| 86060062 | 8606006 | Asthenia | |
| 86060062 | 8606006 | Bradycardia | |
| 86060062 | 8606006 | Dizziness | |
| 86060062 | 8606006 | Drug ineffective | |
| 86060062 | 8606006 | Fatigue | |
| 86060062 | 8606006 | Feeling abnormal | |
| 86060062 | 8606006 | Intentional product misuse | |
| 86060062 | 8606006 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 86060062 | 8606006 | 1 | 2001 | 0 | ||
| 86060062 | 8606006 | 2 | 201004 | 0 |